Cargando…

Improvement of bone defect healing in rats via mesenchymal stem cell supernatant

The effects of mesenchymal stem cells (MSCs) from three different sources in the treatment of bone defect with stem cells, and the differences of curative effects were studied. The umbilical cord, adipose and bone marrow mesen-chymal stem cells (BMSCs) of Sprague-Dawley (SD) rats were isolated and e...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhou, Wanshan, Liu, Qian, Xu, Bo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5774528/
https://www.ncbi.nlm.nih.gov/pubmed/29399126
http://dx.doi.org/10.3892/etm.2017.5534
_version_ 1783293772735447040
author Zhou, Wanshan
Liu, Qian
Xu, Bo
author_facet Zhou, Wanshan
Liu, Qian
Xu, Bo
author_sort Zhou, Wanshan
collection PubMed
description The effects of mesenchymal stem cells (MSCs) from three different sources in the treatment of bone defect with stem cells, and the differences of curative effects were studied. The umbilical cord, adipose and bone marrow mesen-chymal stem cells (BMSCs) of Sprague-Dawley (SD) rats were isolated and extracted, and the phenotype was identified for the 4th generation. The SD rat model of bone defect was established. The rats were randomly divided into: Normal saline group, umbilical cord mesenchymal stem cell (UMSC) group, adipose mesenchymal stem cell (AMSC) group and BMSC group. Rats were treated with tail intravenous injection, followed by radiological examination. The relative expression levels of factors bone morphogenetic protein-2 (BMP-2), osteocalcin (OCN), alkaline phosphatase (ALP), sclerostin (SOST), collagen carboxy-terminal telopeptide (CTX) and tartrated resistant acid phosphatase (TRACP) were measured via fluorescence quantitative PCR and western blotting. Among the three different kinds of stem cell supernatant, the detection using bicinchoninic acid (BCA) method showed that the content of P4-generation new cytokines was the highest. Wound healing in the three stem cell supernatant groups was significant at 3 weeks after operation, which was faster than that in DF12 control group; the expression levels of BMP-2, OCN and ALP in the bone samples treated with three kinds of MSC supernatants after 5 weeks were significantly increased compared with those in control group. The expression levels of SOST, CTX and TRACP were significantly decreased compared with those in control group. Three kinds of MSC supernatants can promote the bone regeneration through promoting the secretion of relatively more osteoblast factors, and inhibit the bone loss. The concentration of cytokines in UMSC supernatant was the highest under the same culture condition, and BMSC supernatant has a better effect in improving the bone defect repair of rats under the same concentration of cytokines.
format Online
Article
Text
id pubmed-5774528
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher D.A. Spandidos
record_format MEDLINE/PubMed
spelling pubmed-57745282018-02-02 Improvement of bone defect healing in rats via mesenchymal stem cell supernatant Zhou, Wanshan Liu, Qian Xu, Bo Exp Ther Med Articles The effects of mesenchymal stem cells (MSCs) from three different sources in the treatment of bone defect with stem cells, and the differences of curative effects were studied. The umbilical cord, adipose and bone marrow mesen-chymal stem cells (BMSCs) of Sprague-Dawley (SD) rats were isolated and extracted, and the phenotype was identified for the 4th generation. The SD rat model of bone defect was established. The rats were randomly divided into: Normal saline group, umbilical cord mesenchymal stem cell (UMSC) group, adipose mesenchymal stem cell (AMSC) group and BMSC group. Rats were treated with tail intravenous injection, followed by radiological examination. The relative expression levels of factors bone morphogenetic protein-2 (BMP-2), osteocalcin (OCN), alkaline phosphatase (ALP), sclerostin (SOST), collagen carboxy-terminal telopeptide (CTX) and tartrated resistant acid phosphatase (TRACP) were measured via fluorescence quantitative PCR and western blotting. Among the three different kinds of stem cell supernatant, the detection using bicinchoninic acid (BCA) method showed that the content of P4-generation new cytokines was the highest. Wound healing in the three stem cell supernatant groups was significant at 3 weeks after operation, which was faster than that in DF12 control group; the expression levels of BMP-2, OCN and ALP in the bone samples treated with three kinds of MSC supernatants after 5 weeks were significantly increased compared with those in control group. The expression levels of SOST, CTX and TRACP were significantly decreased compared with those in control group. Three kinds of MSC supernatants can promote the bone regeneration through promoting the secretion of relatively more osteoblast factors, and inhibit the bone loss. The concentration of cytokines in UMSC supernatant was the highest under the same culture condition, and BMSC supernatant has a better effect in improving the bone defect repair of rats under the same concentration of cytokines. D.A. Spandidos 2018-02 2017-11-21 /pmc/articles/PMC5774528/ /pubmed/29399126 http://dx.doi.org/10.3892/etm.2017.5534 Text en Copyright: © Zhou et al. This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs License (https://creativecommons.org/licenses/by-nc-nd/4.0/) , which permits use and distribution in any medium, provided the original work is properly cited, the use is non-commercial and no modifications or adaptations are made.
spellingShingle Articles
Zhou, Wanshan
Liu, Qian
Xu, Bo
Improvement of bone defect healing in rats via mesenchymal stem cell supernatant
title Improvement of bone defect healing in rats via mesenchymal stem cell supernatant
title_full Improvement of bone defect healing in rats via mesenchymal stem cell supernatant
title_fullStr Improvement of bone defect healing in rats via mesenchymal stem cell supernatant
title_full_unstemmed Improvement of bone defect healing in rats via mesenchymal stem cell supernatant
title_short Improvement of bone defect healing in rats via mesenchymal stem cell supernatant
title_sort improvement of bone defect healing in rats via mesenchymal stem cell supernatant
topic Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5774528/
https://www.ncbi.nlm.nih.gov/pubmed/29399126
http://dx.doi.org/10.3892/etm.2017.5534
work_keys_str_mv AT zhouwanshan improvementofbonedefecthealinginratsviamesenchymalstemcellsupernatant
AT liuqian improvementofbonedefecthealinginratsviamesenchymalstemcellsupernatant
AT xubo improvementofbonedefecthealinginratsviamesenchymalstemcellsupernatant